We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.13B
AUM Growth
-$2.03B
Cap. Flow
+$382B
Cap. Flow %
4,191.08%
Top 10 Hldgs %
16.25%
Holding
592
New
147
Increased
69
Reduced
127
Closed
192

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$185M
2
MRVL icon
Marvell Technology
MRVL
+$135M
3
LOGM
LogMein, Inc.
LOGM
+$110M
4
CA
CA, Inc.
CA
+$96.6M
5
HON icon
Honeywell
HON
+$85.8M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$201M
2
PANW icon
Palo Alto Networks
PANW
+$144M
3
GM icon
General Motors
GM
+$119M
4
COST icon
Costco
COST
+$111M
5
BDX icon
Becton Dickinson
BDX
+$104M

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Industrials 17.44%
3 Financials 11.93%
4 Healthcare 11.85%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMAR
376
DELISTED
Smartsheet Inc.
SMAR
$560K 0.01%
+17,900
New +$477K
AYI icon
377
Acuity Brands
AYI
$10.8B
$540K 0.01%
+3,436
New +$493K
PTN
378
CALL
Palatin Technologies
PTN
$13.8M
$465K 0.01%
373
– –
GSKY
379
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$455K 0.01%
+25,299
New +$482K
GM icon
380
General Motors
GM
$76.8B
$453K 0.01%
13,461
-3,241,046
-100% -$119M
ILMN icon
381
Illumina
ILMN
$28.4B
$425K ﹤0.01%
+1,191
New +$382K
ARVN icon
382
Arvinas
ARVN
$572M
$422K ﹤0.01%
+25,000
New +$412K
EVFM
383
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$405K ﹤0.01%
6,667
– –
TTOO
384
DELISTED
T2 Biosystems, Inc
TTOO
$386K ﹤0.01%
10
-51
-84% -$1.68M
GEVO icon
385
CALL
Gevo
GEVO
$382M
$385K ﹤0.01%
97,039,496,262
+97,039,399,222
+99,999,381% +$385B
RUBY
386
DELISTED
Rubius Therapeutics, Inc
RUBY
$382K ﹤0.01%
+15,930
New +$364K
AHCO icon
387
CALL
AdaptHealth
AHCO
$759M
$370K ﹤0.01%
250,001
– –
RWGE
388
CALL
DELISTED
Regalwood Global Energy Ltd. Class A Ordinary Shares
RWGE
$368K ﹤0.01%
250,001
– –
BMRN icon
389
BioMarin Pharmaceuticals
BMRN
$12.4B
$288K ﹤0.01%
2,970
-554,731
-99% -$55.4M
RYTM icon
390
Rhythm Pharmaceuticals
RYTM
$7.96B
$251K ﹤0.01%
8,590
-98,517
-92% -$3.11M
PEN icon
391
Penumbra
PEN
$12.8B
$236K ﹤0.01%
+1,577
New +$221K
LPRO
392
CALL
DELISTED
Open Lending Corp
LPRO
$217K ﹤0.01%
166,667
– –
STNL
393
CALL
DELISTED
Sentinel Energy Services Inc. Class A Common Stock
STNL
$207K ﹤0.01%
166,667
– –
EIDX
394
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$142K ﹤0.01%
+14,200
New +$233K
NTBL
395
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$135K ﹤0.01%
2,381
– –
CARM
396
DELISTED
Carisma Therapeutics
CARM
$115K ﹤0.01%
2,665
-35,358
-93% -$1.38M
OPRA
397
Opera Ltd
OPRA
$1.79B
$93K ﹤0.01%
+10,380
New +$120K
MLNT
398
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$86K ﹤0.01%
4,353
-95,647
-96% -$2.42M
SLS icon
399
CALL
SELLAS Life Sciences
SLS
$2.36B
$76K ﹤0.01%
1,250
-165
-12% -$11.4K
HMNY
400
CALL
DELISTED
Helios and Matheson Analytics Inc.
HMNY
$6K ﹤0.01%
+350,000
New +$3.5M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2018 Portfolio in Review

As of Q3 2018, Alyeska Investment Group held 592 positions worth $9.13B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $382B of net new capital in Q3 2018, opening 147 new positions and adding to 69 existing holdings. Its largest new stake was Marvell Technology: 6,576,490 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $144M trimmed.

  • Alyeska Investment Group's largest Q3 2018 buy was Marvell Technology: 6,576,490 shares worth $127M.
  • Alyeska Investment Group added most to Electronic Arts in Q3 2018, an estimated $185M increase.
  • Alyeska Investment Group's biggest Q3 2018 reduction was Palo Alto Networks, cutting an estimated $144M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q3 2018, selling an estimated $201M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $9.13B portfolio in Q3 2018.
  • Alyeska Investment Group opened 147 new positions and closed 192 in Q3 2018.
  • Alyeska Investment Group's portfolio value fell 18% quarter-over-quarter to $9.13B.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.